North America Advanced Medical Stopcock Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type and End User

Description

List of Tables

The North America advanced medical stopcock market is expected to grow from US$ 335.94 million in 2021 to US$ 430.56 million in 2028; it is estimated to grow at a CAGR of 3.7% from 2022 to 2028. The market growth is mainly attributed to factors such as the growing incidence of chronic diseases and a surge in the number of surgical procedures. However, the safety concerns regarding stopcocks are hampering the market growth.

The North America advanced medical stopcock market is segmented into the US, Canada, and Mexico. The US is the largest market for advanced medical stopcocks, followed by Canada and Mexico. The increasing geriatric population, rising prevalence of chronic diseases such as cancer, favorable reimbursement for intravenous therapy in the homecare setting in the US and Canada are likely to drive the North America advanced medical stopcock market over the forecast period. In addition, the increasing number of surgeries and growing medical tourism in Mexico are likely to foster the growth of the market from 2022 to 2028.

Surge in Number of Surgical Procedures

Medical stopcocks are used with infusion pumps to administer medications through the catheter to a specific part of the body during or after surgical procedures. Infusion therapy is used when other methods are less effective or when the patient needs medication for the long term. Stopcocks are used to provide medicines in a fluid form when the patient is under observation after surgeries. The number of surgical procedures such as caesarean sections is growing across North America. According to the statistics revealed by the CDC, in 2020, approximately 1,148,692 million C-sections were performed in the US. Further, in Canada, ~105,000 C-sections are performed every year, making it the most common hospital-based surgery in the country. In addition, caesarean delivery rates in Mexico are among the highest in the world. Moreover, as per the Centers for Disease Control and Prevention (CDC), every year, ~805,000 people in the US suffer from a heart attack. It has also been estimated that 1 patient in every 34 seconds dies due to cardiovascular disease (CVD) in the country, and ~20.1 million adults have coronary artery disease (CAD). As a result, the number of cardiovascular surgeries has increased across the region. Thus, the surge in CVD patient population is increasing the number of angiography or angioplasty procedures. These procedures require high-pressure stopcocks; hence, the demand for advanced medical stopcocks is also increasing across the region. Thus, the surge in the number of surgical procedures is driving the North America advanced medical stopcock market.

Based on type, the North America advanced medical stopcock market is segmented into low-pressure stopcocks, medium-pressure stopcocks, and high-pressure stopcocks. The low-pressure stopcocks segment held the largest share of the market in 2021, and it is expected to register the highest CAGR during the forecast period. The low-pressure stopcocks are designed to control the flow of a liquid or gas by using an on/off diverter cock. The pressure of the low-pressure stopcock is 200 psi. These stopcocks offer various advantages such as accuracy, convenience, and flow control per the requirement. The low-pressure stopcock is available in one-way, two-way, and three-way configurations. These enable inserting different fluids in different ways. The low-pressure stopcocks are used in medical and laboratory practices and enable the treatment of patients who require an accurate flow of medicines. Based on end user, the North America advanced medical stopcock market is segmented into hospitals & clinics, homecare, and ambulatory surgery centers. The hospitals & clinics segment held the largest share of the market in 2021.

The World Health Organization (WHO), National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC), American Society for Clinical Pathology, American Diabetes Association, and Globocan are among the major primary and secondary sources referred to while preparing the report on the North America advanced medical stopcock market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the advanced medical stopcock market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the North America advanced medical stopcock market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: TIPRE00004651

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Advanced Medical Stopcock Market - By Type
- 1.3.2 North America Advanced Medical Stopcock Market - By End Use
- 1.3.3 North America Advanced Medical Stopcock Market- By Country

2. North America Advanced Medical Stopcock Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Advanced Medical Stopcock Market- Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America - PEST Analysis
4.3 Experts Opinion
4.4 North America Advanced Medical Stopcock Market (Non-Sterile) to Bulk Packaging Organisation, By Country
4.5 North America Advanced Medical Stopcock Market (Sterile) to End User (Hospital, Retail firm etc.), By Country

5. Advanced Medical Stopcock Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Growing Incidence of Chronic Diseases
- 5.1.2 Surge in Number of Surgical Procedures
5.2 Market Restraints
- 5.2.1 Safety Concerns Regarding Stopcocks
5.3 Market Opportunities
- 5.3.1 Growing Medical Device Industry
5.4 Future Trends
- 5.4.1 IV Therapy
5.5 Impact Analysis

6. Advanced Medical Stopcock Market- North America Analysis

6.1 North America Advanced Medical Stopcock Market Revenue Forecast and Analysis
- 6.1.1 Company Analysis
6.2 Comparative Company Analysis
- 6.2.1 Growth Strategy Analysis
- 6.2.2 Market Positioning of Key Players in Advanced Medical Stopcock Market
  - 6.2.2.1 B. Braun Melsungen AG
  - 6.2.2.2 Smiths Medical Inc

7. Advanced Medical Stopcock Market Analysis and Forecasts To 2028 - By Type

7.1 Overview
7.2 North America Advanced Medical Stopcock Market, By Clinical Indication 2021 & 2028 (%)
7.3 Low-Pressure Stopcocks
- 7.3.1 Overview
- 7.3.2 Low-Pressure Stopcocks Market Revenue and Forecast to 2028 (US$ Million)
7.4 Medium-Pressure Stopcocks
- 7.4.1 Overview
- 7.4.2 Medium-Pressure Stopcocks Market Revenue and Forecast to 2028 (US$ Million)
7.5 High-Pressure Stopcocks Market
- 7.5.1 Overview
- 7.5.2 High-Pressure Stopcocks Market Revenue and Forecast to 2028 (US$ Million)

8. Advanced Medical Stopcock Market Analysis and Forecasts To 2028 - By End User

8.1 Overview
8.2 North America Advanced Medical Stopcock Market, By End User 2021 & 2028 (%)
8.3 Hospitals & Clinics
- 8.3.1 Overview
- 8.3.2 Hospitals & Clinics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Ambulatory Surgery Centers Market
- 8.4.1 Overview
- 8.4.2 Ambulatory Surgery Centers Market Revenue and Forecast to 2028 (US$ Million)
8.5 Homecare Institutes
- 8.5.1 Overview
- 8.5.2 Homecare Market Revenue and Forecast to 2028 (US$ Million)

9. North America Advanced Medical Stopcock Market - Country Analysis

9.1 North America: Advanced Medical Stopcock Market
- 9.1.1 Overview
- 9.1.2 North America: Advanced Medical Stopcock Market - Revenue and Forecast to 2028 (USD Million)
- 9.1.3 North America Advanced Medical Stopcock Market, by Type - Revenue and Forecast to 2028 (USD Million)
- 9.1.4 North America Advanced Medical Stopcock Market, by End User - Revenue and Forecast to 2028 (USD Million)
- 9.1.5 North America: Advanced Medical Stopcock Market, by Country, 2021 & 2028 (%)
  - 9.1.5.1 US: Advanced Medical Stopcock Market - Revenue and Forecast to 2028 (USD Million)
    - 9.1.5.1.1 US: Advanced Medical Stopcock Market - Revenue and Forecast to 2028 (USD Million)
    - 9.1.5.1.2 US Advanced Medical Stopcock Market, by Type - Revenue and Forecast to 2028 (USD Million)
    - 9.1.5.1.3 US: Advanced Medical Stopcock Market, by End User - Revenue and Forecast to 2028 (USD Million)
  - 9.1.5.2 Canada: Advanced Medical Stopcock Market - Revenue and Forecast to 2028 (USD Million)
    - 9.1.5.2.1 Canada: Advanced Medical Stopcock Market - Revenue and Forecast to 2028 (USD Million)
    - 9.1.5.2.2 Canada Advanced Medical Stopcock Market, by Type - Revenue and Forecast to 2028 (USD Million)
    - 9.1.5.2.3 Canada Advanced Medical Stopcock Market, by End User - Revenue and Forecast to 2028 (USD Million)
  - 9.1.5.3 Mexico: Advanced Medical Stopcock Market - Revenue and Forecast to 2028 (USD Million)
    - 9.1.5.3.1 Mexico: Advanced Medical Stopcock Market - Revenue and Forecast to 2028 (USD Million)
    - 9.1.5.3.2 Mexico Advanced Medical Stopcock Market, by Type - Revenue and Forecast to 2028 (USD Million)
    - 9.1.5.3.3 Mexico Advanced Medical Stopcock Market, by End User - Revenue and Forecast to 2028 (USD Million)

10. North America: Impact Assessment of COVID-19 Pandemic

11. Advanced Medical Stopcock Market-Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Advanced Medical Stopcock Market
11.3 Inorganic Growth Strategies
- 11.3.1 Overview
11.4 Organic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 B. Braun Melsungen AG
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Smiths Medical Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Nipro Corp
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Elcam Medical Group Co
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Merit Medical Systems Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 CODAN US Corp
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Nordson Corp
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Cook Medical LLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 JCM MED SaRL
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Utah Medical Products Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms